AI-Powered Drug Discovery Platforms Transforming Biotech
Artificial intelligence is rapidly redefining the architecture of drug discovery across the United States. AI-powered drug discovery platforms are no longer experimental add-ons to traditional research workflows but integrated engines shaping target identification, molecule design, and clinical candidate selection. As capital efficiency pressures intensify and regulatory scrutiny remains high, biotech executives are increasingly evaluating how … Read more